Kilitch Drugs Statements
KI
Kilitch Drugs Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
766.13
100
503.24
67.8
262.89
32.2
—
0
48.782
5.3
186.76
18.5
76.131
13.7
-29.21
-3
34.273
1.1
81.194
11.8
26.971
3.6
65.035
8
4.09
15.886
777.59
100
425.9
55.6
351.69
44.4
—
0
51.349
6.3
219.77
25.5
131.92
18.9
-30.083
-3.7
10.516
1.2
112.35
16.5
30.823
4.1
80.981
11.5
5.08
15.898
754.49
100
468.1
68.1
286.4
31.9
—
0
58.682
6.4
202.88
20.2
83.519
11.7
-24.955
-2.7
17.07
2.2
75.634
11.2
29.541
4.9
59.341
7.8
3.804
15.598
641.5
100
393.74
56.9
247.76
43.1
—
0
58.653
10
191.13
33.1
56.634
10
-24.234
-5.7
12.11
0.8
44.51
5.1
7.775
-1.2
45.14
7.9
2.9
15.566
710.39
100
439.65
59.5
270.74
40.5
—
0
32.026
4.5
225.89
29.8
44.847
10.7
-9.478
-1.9
16.874
1
52.243
9.8
23.116
3.5
40.23
7.9
2.584
15.586
431.95
100
269.5
61.4
162.45
38.6
—
0
29.805
6.7
128.26
26
34.188
12.6
-2.506
-0.5
12.219
0.7
43.901
12.7
10.891
1.8
33.442
9.1
2.15
15.571
402.62
100
247.73
69.6
154.89
30.4
—
0
27.58
6.8
131.45
31.3
23.442
-0.9
-2.815
-0.8
18.773
7.6
39.4
5.9
10.415
2.3
29.182
3.6
1.89
15.443
282.6
100
170.2
51.4
112.5
48.6
—
0
24.7
7.3
103.8
35
8.6
13.6
-4.7
-1
7.9
2.3
11.9
15
3.1
2.8
7.5
11.5
0.48
15.5
275.5
100
176.5
65.2
99
34.8
—
0
29.6
13.2
118
59.1
-19
-24.4
-4
-2
21.6
12.7
-1.4
-13.7
1.7
-2.9
-3
-10.8
-0.18
15.4
257.7
100
159.2
53.7
98.5
46.3
—
0
27.3
9.1
97.5
38.1
0.9
8.2
-3.1
-1.04
19.7
3.8
17.4
11
5.9
2.2
11.5
8.7
0.74
15.15